Back to CA Caption Management, LLC
DSGN2 quarters
Position history for CACaption Management, LLC's holdings in DESIGN THERAPEUTICS INC
Yes. Caption Management holds 1,118,098 shares of DSGN (Design Therapeutics), worth $16.2M, as of its Q2 2026 13F filing. It increased the position from 86,708 shares in Q1 2026. Caption Management has held DSGN since Q1 2026, across 2 quarterly 13F filings. DSGN is 0.1% of Caption Management's reported 13F portfolio.
Current Value
$16.2M
Current Shares
1.1M
Total Value Change
+$15.3M
Total Shares Change
+1M
Quarter-by-Quarter History
Other major holders of DSGN: CITADEL ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Point72 Asset Management, L.P.